Genmab

GMAB · Nasdaq Copenhagen · DKK

kr 2,257.00−2.42%−kr 56.00

Close · October 2, 2026

At a glance

Revenue growth
+19.19%
2025 vs 2024
Net income growth
−15.00%
2025 vs 2024
Net margin
25.9%
2024: 36.3%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets12,51512,37612,8737,0216,4646,5866,4145,9325,5495,3055,2334,998
Current assets2,8012,5732,8854,4713,9104,0373,9003,5443,1524,9714,9144,684
Cash and equivalents1,5031,5211,7151,7611,2961,6191,3809496222,1222,2052,024
Short-term investments——0.01,6501,6031,6071,574—1,6382,1571,9681,880
Receivables1,2731,0271,1521,046998799937944886677734770
Inventory18.021.018.014.013.012.09.010.65.215.38.59.9
Net property, plant and equipment254265280266277271265269270269243234
Goodwill355355355355355355355360362———
Other intangible assets8,8728,9489,1231,7481,7521,7561,7281,7211,7263.315.016.3
Long-term investments39.041.037.036.035.030.032.028.328.222.119.922.1
Current liabilities1,1401,1781,427741629756744686627399368412
Long-term debt4,8414,9335,001—————————
Total debt5,2735,3515,426142148———————
Total liabilities6,5586,6947,0261,2701,1621,2901,2771,1571,099605546585
Total equity (incl. minority)5,9575,6825,8475,7515,3025,2965,1374,7744,4494,7004,6884,413
Retained earnings4,4214,0904,0984,0323,5983,5373,3922,9352,6052,8642,8212,617